The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis
Abstract
The molecular mechanisms by which obesity increases the risk of cardiovascular diseases are poorly understood. The purpose of this study was to identify candidate biomarkers overexpressed in adipose tissue of obese subjects that could link expanded fat mass to atherosclerosis. We compared gene expression profile in subcutaneous adipose tissue (scWAT) of 28 obese and 11 lean subjects using microarray technology. This analysis identified 240 genes significantly overexpressed in scWAT of obese subjects. The genes were then ranked according to the correlation between gene expression and body mass index (BMI). In this list, the elastolytic cysteine protease cathepsin S was among the highly correlated genes. RT‐PCR and Western blotting confirmed the increase in cathepsin S mRNA ( P =0.006) and protein ( P <0.05) in obese scWAT. The circulating concentrations of cathepsin S were also significantly higher in obese than in nonobese subjects ( P <0.0001). Both cathepsin S mRNA in scWAT and circulating levels were positively correlated with BMI, body fat, and plasma triglyceride levels. In addition, we show that the proinflammatory factors, lipopolysaccharide, interleukin‐lβ, and tumor necrosis factor‐α increase cathepsin S secretion in human scWAT explants. This study identifies cathepsin S as a novel marker of adiposity. Since this enzyme has been implicated in the development of atherosclerotic lesions, we propose that cathepsin S represents a molecular link between obesity and atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the genes showing the strongest association with the BMI were cathepsin S (CTSS), involved in the degradation of several components of the extracellular matrix [19], lymphocyte cytosolic protein 2 (LCP2) and CD247 (CD247), both related to T cell development and activation, as well as the hypoxia-inducible factor 1 (HIF1A).”
From Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity (2008) · cites this paper as [19]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“Insulin sensitivity was evaluated using QUICKI index (20).”
MethodHotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0372 · Cited by 1,395
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Meier, U., & Gressner, A. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032482 · Cited by 1,048
EMERGING ROLES FOR CYSTEINE PROTEASES IN HUMAN BIOLOGY
Chapman, H. A., Riese, R. J., & Shi, G. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.63 · Cited by 793
Research works printed but not linked: 1
- 10.1177/107155760000700309 · DOI
Cited by
Sorted by citations
Fain, J. N. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74018-3 · Cited by 702
Henegar, C., Tordjman, J., Achard, V., Lacasa, D., Cremer, I., Guerre-Millo, M., Poitou, C., Basdevant, A., Stich, V., Viguerie, N., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-1-r14 · Cited by 471
Self-citationChemerin: at the crossroads of inflammation and obesity
Ernst, M. C., & Sinal, C. J. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.001 · Cited by 431
Cathepsin cysteine proteases in cardiovascular disease
Lutgens, S. P. M., Cleutjens, K. B. J. M., Daemen, M. J. A. P., & Heeneman, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7924com · Cited by 351
Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 287
Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus
Balasubramanian, S. A., Mohan, S., Pye, D. C., & Willcox, M. D. P. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02369.x · Cited by 261
Dalmas, É., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron‐Wisnewsky, J., Lacroix‐Desmazes, S., Bayry, J., Kaveri, S. V., Clément, K., et al. (2014) · Diabetes · doi:10.2337/db13-1511 · Cited by 256
Self-citationCathepsin S: therapeutic, diagnostic, and prognostic potential
Wilkinson, R. D. A., Williams, R. D., Scott, C. J., & Burden, R. E. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0114 · Cited by 219
Cathepsin K inhibitors for osteoporosis and potential off-target effects
Brömme, D., & Lecaille, F. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902832661 · Cited by 219
Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue
Divoux, A., & Clément, K. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00811.x · Cited by 227
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 213
Biochemical properties and regulation of cathepsin K activity
Lecaille, F., Brömme, D., & Lalmanach, G. (2007) · Biochimie · doi:10.1016/j.biochi.2007.08.011 · Cited by 183
Potential Contribution of Adipose Tissue to Elevated Serum Cystatin C in Human Obesity
Naour, N., Fellahi, S., Renucci, J., Poitou, C., Rouault, C., Basdevant, A., Dutour, A., Alessi, M., Bastard, J., Clément, K., et al. (2009) · Obesity · doi:10.1038/oby.2009.96 · Cited by 171
Self-citationHuber, J., Löffler, M. G., Bilban, M., Reimers, M., Kadl, A., Todoric, J., Zeyda, M., Geyeregger, R., Schreiner, M., Weichhart, T., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803511 · Cited by 154
Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential
Smyth, P., Sasiwachirangkul, J., Williams, R. D., & Scott, C. J. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101106 · Cited by 155
Taleb, S., Cancello, R., Clément, K., & Lacasa, D. (2006) · Endocrinology · doi:10.1210/en.2006-0386 · Cited by 145
Self-citationMucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease
Basson, A. R., Trotter, A., Rodriguez‐Palacios, A., & Cominelli, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00290 · Cited by 140
The Problem of Wound Healing in Diabetes—From Molecular Pathways to the Design of an Animal Model
Mieczkowski, M., Mrozikiewicz‐Rakowska, B., Kowara, M., Kleibert, M., & Czupryniak, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147930 · Cited by 150
Cathepsins and cystatin C in atherosclerosis and obesity
Lafarge, J.-C., Naour, N., Clément, K., & Guerre-Millo, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.011 · Cited by 118
Lackey, D. E., Burk, D. H., Ali, M. R., Mostaedi, R., Smith, W. H., Park, J., Scherer, P. E., Seay, S. A., McCoin, C. S., Bonaldo, P., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00476.2013 · Cited by 111
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
Wu, H., Du, Q., Dai, Q., Ge, J., & Cheng, X. W. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17016 · Cited by 111
Cho, S., Choi, Y., Park, S., & Park, T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.016 · Cited by 109
The usefulness of circulating adipokine levels for the assessment of obesity-related health problems
Inadera, H. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.248 · Cited by 109
Kwon, E., Shin, S., Cho, Y.-Y., Jung, U. J., Kim, E., Park, T., Park, J. H. Y., Yun, J. W., McGregor, R. A., Park, Y. B., et al. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-450 · Cited by 111
Kininogens: More than cysteine protease inhibitors and kinin precursors
Lalmanach, G., Naudin, C., Lecaille, F., & Fritz, H. (2010) · Biochimie · doi:10.1016/j.biochi.2010.03.011 · Cited by 109
Hua, Y., & Nair, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.032 · Cited by 102
Naour, N., Rouault, C., Fellahi, S., Lavoie, M.-È., Poitou, C., Kéophiphath, M., Eberlé, D., Shoelson, S. E., Rizkalla, S. W., Bastard, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1894 · Cited by 102
Self-citationShould Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., Anagnostis, P. G., Mikhailidis, D. P., Fiorino, G., Rovida, S., Correale, C., Malesci, A., & Danese, S. (2009) · Current Drug Targets · doi:10.2174/138945010790030992 · Cited by 102
Regulation of inflammation-related genes in human adipose tissue
Clement, K., & Langin, D. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01851.x · Cited by 98
Self-citationMast Cell Tryptase Deficiency Attenuates Mouse Abdominal Aortic Aneurysm Formation
Zhang, J., Sun, J., Lindholt, J. S., Sukhova, G. K., Sinnamon, M. J., Stevens, R. L., Adachi, R., Libby, P., Thompson, R. W., & Shi, G. (2011) · Circulation Research · doi:10.1161/circresaha.111.243758 · Cited by 92
Cathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction
Hua, Y., Zhang, Y., Dolence, J. M., Shi, G., Ren, J. T., & Nair, S. (2012) · Diabetes · doi:10.2337/db12-0350 · Cited by 87
Yang, M., Sun, J., Zhang, T., Liu, J., Zhang, J., Shi, M. A., Darakhshan, F., Guerre-Millo, M., Clément, K., Gelb, B. D., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.172320 · Cited by 84
Pathophysiology of osteoporosis
Sipos, W., Pietschmann, P., Rauner, M., Kerschan‐Schindl, K., & Patsch, J. (2009) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-009-0647-y · Cited by 85
Choi, Y., Kim, Y., Park, S., Lee, K. W., & Park, T. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.005 · Cited by 79
Association between serum cathepsin S and mortality in older adults.
Jobs, E., Ingelsson, E., Risérus, U., Nerpin, E., Jobs, M., Sundström, J., Basu, S., Larsson, A., Lind, L., & Ärnlöv, J. (2011) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2011.1246 · Cited by 53
Meta-analysis of genome-wide association data identifies novel susceptibility loci for obesity
Pei, Y., Zhang, L., Liu, Y., Li, J. M., Shen, H., Liu, Y.-Z., Tian, Q., He, H., Wu, S., Ran, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt464 · Cited by 80
Kwon, E., & Choi, M. (2018) · Nutrients · doi:10.3390/nu10101415 · Cited by 77
Li, X., Wu, K., Edman, M. C., Schenke‐Layland, K., MacVeigh‐Aloni, M., Janga, S. R., Schulz, B., & Hamm‐Alvarez, S. F. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4523 · Cited by 74
Fain, J. N., Tichansky, D. S., & Madan, A. K. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.008 · Cited by 73
Upregulation of cathepsin S in psoriatic keratinocytes
Schönefuß, A., Wendt, W., Schattling, B., Schulten, R., Hoffmann, K. H., Stüecker, M., Tigges, C., Lübbert, H., & Stichel, C. C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00990.x · Cited by 71
Dehghan, F., Soori, R., Gholami, K., Abolmaesoomi, M., Yusof, A., Muniandy, S., Heidarzadeh, S., Farzanegi, P., & Azarbayjani, M. A. (2016) · Scientific Reports · doi:10.1038/srep37819 · Cited by 68
Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women
Taleb, S., Cancello, R., Poitou, C., Rouault, C., Sellam, P., Levy, P., Bouillot, J.-L., Coussieu, C., Basdevant, A., Guerre-Millo, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1601 · Cited by 67
Self-citationVupputuri, S. X., Fox, C. S., Coresh, J., Woodward, M., & Muntner, P. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.043 · Cited by 65
Yang, L., He, T., Xiong, F., Chen, X., Fan, X., Jin, S., & Geng, Z. (2020) · BMC Genomics · doi:10.1186/s12864-020-6713-y · Cited by 61
The S2 subsites of cathepsins K and L and their contribution to collagen degradation
Lecaille, F., Chowdhury, S. F., Purisima, E. O., Brömme, D., & Lalmanach, G. (2007) · Protein Science · doi:10.1110/ps.062666607 · Cited by 61
Qin, Y., & Shi, G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.010 · Cited by 60
High levels of cathepsin D and cystatin B are associated with increased risk of coronary events
Gonçalves, I., Hultman, K., Dunér, P., Edsfeldt, A., Hedblad, B., Fredrikson, G. N., Björkbacka, H., Nilsson, J. Å., & Bengtsson, E. (2016) · Open Heart · doi:10.1136/openhrt-2015-000353 · Cited by 58
Cathepsin K Null Mice Show Reduced Adiposity during the Rapid Accumulation of Fat Stores
Funicello, M., Novelli, M., Ragni, M., Vottari, T., Cocuzza, C., López‐Soriano, J., Chiellini, C., Boschi, F., Marzola, P., Masiello, P., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000683 · Cited by 56
Emerging role of cathepsin S in obesity and its associated diseases
Taleb, S., & Clément, K. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.083 · Cited by 54
Self-citationShea, J. L., French, C. R., Bishop, J., Martin, G., Roebothan, B., Pace, D., Fitzpatrick, D., & Sun, G. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.25970 · Cited by 54
A strategy to search for common obesity and type 2 diabetes genes
Elbers, C. C., Onland‐Moret, N. C., Franke, L., Niehoff, A. G., van der Schouw, Y. T., & Wijmenga, C. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.11.003 · Cited by 51
Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer
Liu, W., Liu, D., Cheng, K., Liu, Y., Xing, S., Chi, P., Liu, X., Xue, N., Lai, Y., Guo, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8582 · Cited by 49
Elastase and Tryptase Govern TNFα-Mediated Production of Active Chemerin by Adipocytes
Parlee, S. D., McNeil, J. O., Muruganandan, S., Sinal, C. J., & Goralski, K. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051072 · Cited by 44
Angiogenesis in Adipose Tissue
Bråkenhielm, E., & Cao, Y. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-245-8_5 · Cited by 45
Jobs, E. N., Risérus, U., Ingelsson, E., Sundström, J., Jobs, M., Nerpin, E., Iggman, D., Basu, S., Larsson, A. O., Lind, L., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0494 · Cited by 43
Integrative analyses of biomarkers and pathways for adipose tissue after bariatric surgery
Liu, Y., Jin, J., Chen, Y., Chen, C., Chen, Z., & Xu, L. (2020) · Adipocyte · doi:10.1080/21623945.2020.1795434 · Cited by 42
Jobs, E., Risérus, U., Ingelsson, E., Helmersson, J., Nerpin, E., Jobs, M., Sundström, J., Lind, L., Larsson, A., Basu, S., et al. (2010) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2010-0328 · Cited by 43
Rauner, M., Föger‐Samwald, U., Kurz, M., Brünner-Kubath, C., Schamall, D., Kapfenberger, A., Varga, P., Kudlacek, S., Wutzl, A., Höger, H., et al. (2014) · Bone · doi:10.1016/j.bone.2014.04.022 · Cited by 40
Wojczynski, M. K., Parnell, L. D., Pollin, T. I., Lai, C., Feitosa, M. F., O’Connell, J. R., Wood, A. C., Gibson, Q., Aslibekyan, S. W., Ryan, K. A., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.001 · Cited by 39
Nishimura, Y., Sasagawa, S., Ariyoshi, M., Ichikawa, S., Shimada, Y., Kawaguchi, K., Kawase, R., Yamamoto, R., Uehara, T., Yanai, T., et al. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00199 · Cited by 36
DNA microarrays to define and search for genes associated with obesity
Kim, Y., & Park, T. (2009) · Biotechnology Journal · doi:10.1002/biot.200900228 · Cited by 36
Roumans, N. J. T., Vink, R., Fazelzadeh, P., van Baak, M. A., & Mariman, E. C. M. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.148874 · Cited by 36
Inflammation, adipokines et obésité
Clément, K., & Vignes, S. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.03.363 · Cited by 40
Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease
Ye, Z., Wang, S., Yang, Z., He, M., Zhang, S., Zhang, W., Wen, J., Li, Q., Huang, Y., Wang, X., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-013-2977-5 · Cited by 35
Kaartinen, M. T., Arora, M., Heinonen, S., Hang, A., Barry, A., Lundbom, J., Hakkarainen, A., Lundholm, N., Rissanen, A., Kaprio, J. A., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00722-0 · Cited by 33
Cathepsin S inhibition lowers blood glucose levels in mice
Lafarge, J.-C., Pini, M., Pelloux, V., Orasanu, G., Hartmann, G. R., Venteclef, N., Sulpice, T., Shi, G., Clément, K., & Guerre-Millo, M. (2014) · Diabetologia · doi:10.1007/s00125-014-3280-2 · Cited by 34
Self-citationDiscovery of Novel Cathepsin S Inhibitors by Pharmacophore-Based Virtual High-Throughput Screening
Markt, P., McGoohan, C., Walker, B., Kirchmair, J., Feldmann, C., Martino, G. D., Spitzer, G. M., Distinto, S., Schuster, D., Wolber, G., et al. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800101j · Cited by 30
Cathepsin S and its inhibitor cystatin C: imbalance in uveal melanoma
Paraoan, L. (2009) · Frontiers in bioscience · doi:10.2741/3393 · Cited by 29
Marmarinos, A., Garoufi, A., Panagoulia, A., Dimou, S., Drakatos, A., Paraskakis, I., & Gourgiotis, D. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.10.012 · Cited by 28
Fontanesi, L., Speroni, C., Buttazzoni, L., Scotti, E., Costa, L. N., Davoli, R., & Russo, V. (2010) · Meat Science · doi:10.1016/j.meatsci.2010.01.023 · Cited by 28
Importance of adipokines in glucose homeostasis
Blüher, M. (2013) · Diabetes Management · doi:10.2217/dmt.13.35 · Cited by 26
The Emerging Relevance of the Cysteine Protease Cathepsin S in Disease
Small, D. M., Burden, R. E., & Scott, C. J. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9095-5 · Cited by 25
Poussin, C., Hall, D., Minehira, K., Galzin, A., Tarussio, D., & Thorens, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003385 · Cited by 24
Takayama, F., Zhang, X., Hayashi, Y., Wu, Z., & Nakanishi, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.061 · Cited by 22
Cysteinyl Cathepsins: Multifunctional Enzymes in Cardiovascular Disease
Li, X., Liu, Z., Cheng, Z., & Cheng, X. W. (2012) · Chonnam Medical Journal · doi:10.4068/cmj.2012.48.2.77 · Cited by 21
Sage, J., de Quéral, D., Noblesse, E., Kurfürst, R., Schnebert, S., Perrier, É., Nizard, C., Lalmanach, G., & Lecaille, F. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.07.002 · Cited by 20
Differentially Expressed Genes and Enriched Signaling Pathways in the Adipose Tissue of Obese People
Lu, Z., Meng, L., Sun, Z., Shi, X., Shao, W., Zheng, Y., Yao, X., & Song, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.620740 · Cited by 20
Brahe, L. K., Ängquist, L. H., Larsen, L. H., Vimaleswaran, K. S., Hager, J., Viguerie, N., Loos, R. J. F., Handjieva‐Darlenska, T., Jebb, S. A., Hlavatý, P., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512006058 · Cited by 21
Self-citationMobilization of pro-inflammatory lipids in obese Plscr3-deficient mice
Mutch, D. M., O’Maille, G., Wikoff, W. R., Wiedmer, T., Sims, P. J., & Siuzdak, G. E. (2007) · Genome biology · doi:10.1186/gb-2007-8-3-r38 · Cited by 20
Romier, B., Dray, C., Vanalderwiert, L., Wahart, A., Hocine, T., Dortignac, A., Garbar, C., Garbar, C., Boulagnon‐Rombi, C., Bouland, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01735-z · Cited by 19
Befekadu, R., Christiansen, K., Larsson, A. O., & Grenegård, M. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0030 · Cited by 19
(1980) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-8914-9 · Cited by 19
Kim, J. Y., Wu, Y., & Smas, C. M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00206.2006 · Cited by 19
Vázquez, R., Astorgues‐Xerri, L., Békradda, M., Gormley, J. A., Buick, R. J., Kerr, P., Cvitkovic, E., Raymond, É., D’Incalci, M., Frapolli, R., et al. (2014) · Biochimie · doi:10.1016/j.biochi.2014.10.025 · Cited by 18
Influence of a prudent diet on circulating cathepsin S in humans
Jobs, E. N., Adamsson, V., Larsson, A. O., Jobs, M., Nerpin, E., Ingelsson, E., Ärnlöv, J., & Risérus, U. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-84 · Cited by 18
Circulating cathepsin S improves glycaemic control in mice
Karimkhanloo, H., Keenan, S. N., Sun, E. W. L., Wattchow, D. A., Keating, D. J., Montgomery, M. K., & Watt, M. J. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0408 · Cited by 19
Molecular probes for selective detection of cysteine cathepsins
Schleyer, K. A., & Cui, L. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00225b · Cited by 18
Recommended Nordic diet and risk markers for cardiovascular disease
Berild, A., Holven, K. B., & Ulven, S. M. (2017) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.16.0243 · Cited by 18
Inflammatory markers and frailty in home-dwelling elderly, a cross-sectional study
Bålsrud, P., Ulven, S. M., Christensen, J. J., Ottestad, I. O., & Holven, K. B. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04690-2 · Cited by 17
Zhang, Z.-Y., Mai, Y., Yang, H., Dong, P., Zheng, X., & Yang, G.-S. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2111-6 · Cited by 17
The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans
Sales, V., & Patti, M. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0283-8 · Cited by 17
Al‐Mashhadi, A. L., Poulsen, C. B., von Wachenfeldt, K. A., Robertson, A.-K. L., Bentzon, J. F., Nielsen, L. B., Thygesen, J., Tolbod, L. P., Larsen, J. R., Moestrup, S. K., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/6823193 · Cited by 16
Ahmad, S., Bhagwati, S., Kumar, S., Banerjee, D., & Siddiqi, M. I. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.107512 · Cited by 15
Vincent, A., Louveau, I., Gondret, F., Lebret, B., & Damon, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00098.2012 · Cited by 16
Spielmann, N., Mutch, D. M., Rousseau, F., Torès, F., Hager, J., Bertrais, S., Basdevant, A., Tounian, P., Dubern, B., Galan, P., et al. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01043.x · Cited by 15
Self-citationModification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity
Chen, D. C., Scherzer, R., Ix, J. H., Kramer, H., Crews, D. C., Nadkarni, G. N., Gutiérrez, O. M., Bullen, A. L., Ilori, T. O., Garimella, P. S., et al. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.08.021 · Cited by 14
Cathepsin S: A key drug target and signalling hub in immune system diseases
Geetha, D., & Skaria, T. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114622 · Cited by 15
Integrative analysis of pathway deregulation in obesity
Font-Clos, F., Zapperi, S., & Porta, C. A. M. L. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0018-z · Cited by 14
Dietary Factors Impact on the Association between CTSS Variants and Obesity Related Traits
Hooton, H., Ängquist, L. H., Holst, C., Hager, J., Rousseau, F., Hansen, R. D., Tjønneland, A. M., Roswall, N., van der A, D. L., Overvad, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040394 · Cited by 14
Self-citationPPAR Gamma at the Crossroads of Health and Disease: A Masterchef in Metabolic Homeostasis
Akoum, S. E. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000126 · Cited by 13
Metadata
- Authors
- Taleb, S., Lacasa, D., Bastard, J., Poitou, C., Cancello, R., Pelloux, V., Viguerie, N., Benis, A., Zucker, J., Bouillot, J., Coussieu, C., Basdevant, A., Langin, D., & Clement, K.
- Affiliations
- Inserm (FR)
- INSERM “Avenir” Team and CHRU Pitié Salpétrière Hôtel‐Dieu Nutrition Department Centre de Recherche en Nutrition Humaine F‐75004 Paris
- Hôtel-Dieu de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-06-28
- Volume
- 19
- Issue
- 11
- Pages
- 1540-1542
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2165745035
- Cited by
- 158
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 6 · 2015: 7 · 2014: 10 · 2013: 9 · 2012: 13
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- cathepsin S, adiposity biomarkers, obesity, atherosclerosis, subcutaneous adipose tissue, gene expression profiling, body mass index, cysteine protease, inflammation, lipopolysaccharide, IL-1β, TNF-α, plasma triglycerides, cardiovascular risk
- MeSH terms
- Adipose Tissue, Cathepsins, Female, Humans, Muscle, Smooth, Vascular, Obesity, RNA, Messenger, Biomarkers, Extracellular Matrix Proteins, Adipocytes, Gene Expression Profiling, Adiposity, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review